Brachytherapy · 2025
High-dose-rate brachytherapy for cutaneous T-cell lymphoma involving complex skin sites.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sim Van, Vaz Regina Gonzalez, Jones Emma L, De Francesco Irene, Dobson Adam, Thomas Bjorn R, Morris Stephen
Аннотация
PURPOSE: Mycosis fungoides (MF) is a highly radiosensitive tumor and low dose palliative radiotherapy is an essential treatment modality with excellent results. However, some skin sites with complex, oblique or very curved shape are difficult to treat with conventional radiotherapy techniques. We report our experience using HDR brachytherapy to treat MF in complex skin sites.
MATERIALS AND METHODS: All patients who underwent HDR brachytherapy (HDR BT) for mycosis fungoides from 2014-2023 were included. Superficial brachytherapy molds such as the Freiburg flap applicator and 3D surface mold applicator were used. Following CT acquisition, the Oncentra treatment planning software was used to generate a treatment plan. Clinical response locally was assessed using the Olsen criteria and toxicities were recorded on the skin tumor unit database.
RESULTS: Thirty-nine (39) skin lesions within complex, and oblique and/or curved sites in 28 patients were treated with HDR BT. Local complete response rate is 100% with a mean follow up of 33 months. Sites treated were the face (n = 5), arms (n = 5), hands (n = 17), legs (n = 4), and feet (n = 8). Dose and fractionations used were 8 Gy/2F/2 days, 9 Gy/3F/3d, 12 Gy/3F/3d and 20 Gy/10F/2 weeks. Sixty percent were retreatment sites with a prior mean cumulative dose of 34 Gy (EQD2 α/β = 3). The mean D80% for all sites was 96.8% (range 85.6%-99.9%) with D0.1cc and D2cc to the involved skin 112.6% (range 101.5%-130.7%) and 102.5% (range 93.7%-117.3%) respectively. Complete response was achieved in 100%. Rate of G3 toxicity was 2.6% and G2 toxicity was 10.3%.
CONCLUSION: HDR BT is a safe and effective technique to treat MF lesions situated in regions of high obliquity and/or curvature with an acceptable toxicity rate.
MATERIALS AND METHODS: All patients who underwent HDR brachytherapy (HDR BT) for mycosis fungoides from 2014-2023 were included. Superficial brachytherapy molds such as the Freiburg flap applicator and 3D surface mold applicator were used. Following CT acquisition, the Oncentra treatment planning software was used to generate a treatment plan. Clinical response locally was assessed using the Olsen criteria and toxicities were recorded on the skin tumor unit database.
RESULTS: Thirty-nine (39) skin lesions within complex, and oblique and/or curved sites in 28 patients were treated with HDR BT. Local complete response rate is 100% with a mean follow up of 33 months. Sites treated were the face (n = 5), arms (n = 5), hands (n = 17), legs (n = 4), and feet (n = 8). Dose and fractionations used were 8 Gy/2F/2 days, 9 Gy/3F/3d, 12 Gy/3F/3d and 20 Gy/10F/2 weeks. Sixty percent were retreatment sites with a prior mean cumulative dose of 34 Gy (EQD2 α/β = 3). The mean D80% for all sites was 96.8% (range 85.6%-99.9%) with D0.1cc and D2cc to the involved skin 112.6% (range 101.5%-130.7%) and 102.5% (range 93.7%-117.3%) respectively. Complete response was achieved in 100%. Rate of G3 toxicity was 2.6% and G2 toxicity was 10.3%.
CONCLUSION: HDR BT is a safe and effective technique to treat MF lesions situated in regions of high obliquity and/or curvature with an acceptable toxicity rate.